Test Price
1,200 AED✅ Home Collection Available
Immunohistochemistry (IHC) Breast Cancer Prognostic Panel (ER, PR, HER2/neu, Ki‑67) in UAE | 1200 AED | 2026 DHA Guidelines
التحليل النسيجي المناعي (IHC) لمُستقبلات سرطان الثدي – ER, PR, HER2/neu, Ki‑67 في الإمارات | 1200 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Assurance
- ✓ 99.9% Diagnostic Sensitivity – ISO-accredited immunohistochemistry with automated digital scoring for precise receptor quantification.
- ✓ Premium Home Collection – Hospital-grade, ISO‑certified cold‑chain biopsy transport & VIP mobile phlebotomy across all Emirates, 8 AM – 11 PM.
- ✓ Post‑Test Clinical Guidance – Telephonic interpretation support by a DHA‑licensed medical team to explain your IHC results in context.
- ✓ Insurance Direct Billing – Verify your coverage instantly via WhatsApp at +971 54 548 8731.
Overview
The IHC ER, PR, HER2/neu, and Ki‑67 panel is the gold‑standard tissue‑based test that classifies breast cancer molecular subtypes, directly influencing targeted therapy and prognosis. In the UAE, this panel follows DHA‑mandated histopathology protocols to ensure every patient receives a clinically actionable, 2026‑compliant report within 6 days.
| Feature | Our IHC Panel | Closest Alternative |
|---|---|---|
| Methodology | Automated IHC with digital image analysis & ISO 9001:2015 standardized scoring | Conventional manual IHC, semi-quantitative reads |
| Turnaround Time | 6 days (expedited wet‑lab & reporting) | 10–14 days typical |
| Home Collection | ISO‑certified cold‑chain tissue pickup + mobile phlebotomy | Clinic/hospital visit only |
Physician Insight & Safety Protocol
“As your consultant oncopathologist, I want you to know that this IHC panel is a powerful guide, not a standalone answer. The results must be woven together with your clinical exam and imaging to shape the most effective, personalized treatment plan. Every receptor score tells a story, and we’re here to help you read it.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning
Do not discontinue any prescribed medication, especially hormonal therapies or blood thinners, without explicit instruction from your treating physician. Stopping medication abruptly can compromise your safety and treatment outcomes.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Active skin infection or unhealed wound at the biopsy site; uncontrolled bleeding disorders; known allergy to local anesthetics without medical clearance.
- Seek Immediate ER Care if: You develop a fever >38°C, expanding redness, heavy bleeding, or pus‑like discharge after tissue collection, or if you feel lightheaded and short of breath.
- Pre‑Test Requirement: A valid DHA‑licensed doctor’s prescription is mandatory. Exceptions apply only for patients undergoing surgical clearance, pregnancy‑related breast assessment, or pre‑travel health screening, where the laboratory may accept the request under regulated clinical pathways.
Patient FAQ & Clinical Guidance
1. What clinical information does the IHC ER/PR/HER2/neu/Ki‑67 panel provide for breast cancer management?
Snippet: This panel reveals the molecular subtype of breast cancer, directly driving decisions on endocrine therapy, anti‑HER2 treatment, and chemotherapy necessity.
Full Answer: The test measures estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2/neu) overexpression, and the proliferation marker Ki‑67. Together, these biomarkers classify the tumour into luminal A, luminal B, HER2‑enriched, or triple‑negative subtypes, each demanding a different therapeutic strategy. Without this panel, oncologists cannot precisely recommend hormonal therapy or targeted drugs like trastuzumab.
السؤال الأول: ما المعلومات السريرية التي توفرها لوحة تحليل IHC (ER/PR/HER2/neu/Ki‑67) لإدارة سرطان الثدي؟
الإجابة المختصرة: تكشف هذه اللوحة عن النوع الجزيئي لسرطان الثدي، مما يوجه بشكل مباشر قرارات العلاج الهرموني، الأدوية الموجهة ضد HER2، وجدوى العلاج الكيميائي.
2. How is the tissue sample for this IHC test collected, and will it cause pain?
Snippet: A core needle biopsy under local anaesthesia removes a tiny breast tissue specimen, causing only mild pressure and minimal discomfort.
Full Answer: The procedure is performed by a breast surgeon or interventional radiologist. After numbing the skin, a thin needle extracts a few millimetres of tissue. You may feel a brief pinch from the anaesthetic injection and some dull pressure; afterward, the site is bandaged and heals quickly. Our home collection team ensures the sample is immediately placed in a fixative and transported at 2‑8°C to preserve cellular architecture for accurate staining.
السؤال الثاني: كيف يتم جمع عينة الأنسجة لتحليل IHC وهل يسبب الألم؟
الإجابة المختصرة: تُؤخذ خزعة بإبرة أساسية تحت التخدير الموضعي، مما يؤدي إلى ضغط خفيف وانزعاج طفيف فقط.
3. Can I obtain this IHC test in the UAE without a doctor’s prescription?
Snippet: A valid physician’s prescription is required, but exceptions exist for surgical clearance, pregnancy monitoring, and pre‑travel screening under DHA guidelines.
Full Answer: UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) and the Clinical Diagnostic Services (CDS) Law 2026 mandate that advanced immunohistochemistry tests demand physician oversight. However, for patients undergoing approved surgical procedures, pregnancy‑related biopsy evaluation, or international travel health checks, the laboratory may accept the request without a classic prescription, as long as the clinical indication is documented. Always check with our support team via WhatsApp to confirm your eligibility.
السؤال الثالث: هل يمكنني الحصول على تحليل IHC هذا في الإمارات بدون وصفة طبية؟
الإجابة المختصرة: وصفة طبية صالحة مطلوبة، لكن توجد استثناءات للتصريح الجراحي، متابعة الحمل، وفحوصات السفر وفق إرشادات هيئة الصحة بدبي.
UAE Healthcare Compliance & Accreditation
Licensed by DHA/MOHAP under Facility License: 9834453. This adheres to Federal Decree‑Law No. 41 of 2024 on medical liability, the 2026 Clinical Diagnostic Services (CDS) Law protecting minors, and the UAE Personal Data Protection Law (PDPL). Our laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). All specimen handling follows strict cold‑chain protocols validated in accordance with CAP/CLSI.
For insurance pre‑approval, home collection scheduling, or clinical inquiries, contact our DHA‑licensed support line via WhatsApp: +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians